BT
Bhuvan Talanki Mohan
About Bhuvan Talanki Mohan
Bhuvan Talanki Mohan has 8 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Mytimeequity Business Solutions Private Limited and Maxor Developers Llp. Formerly with 1 company, such as Bcv Developers Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Mytimeequity Business Solutions Private Limited
U74909KA2025FTC203761
|
Director | 06 Jun 2025 | 2025 | Active |
Maxor Developers Llp
ACJ-6711
|
Designated Partner | 28 Sep 2024 | 2024 | Active |
Suma Monde Kapital Partners Private Limited
U74909KA2024FTC188746
|
Director | 21 May 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Bcv Developers Private Limited
U45201KA2008PTC045861
|
Cfo | 26 Jul 2018 | 2008 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhuvan Talanki Mohan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhuvan Talanki Mohan
Bhuvan Talanki Mohan has 8 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Mytimeequity Business Solutions Private Limited and Maxor Developers Llp. Formerly with 1 company, such as Bcv Developers Private Limited. Engaged in General Business. Contributes to corporate operations.
Bhuvan Talanki Mohan is associated with 3 companies as Director and Designated Partner.
Bhuvan Talanki Mohan has expertise in General Business.
Bhuvan Talanki Mohan has 8 years in corporate governance.